292
Participants
Start Date
June 28, 2021
Primary Completion Date
June 14, 2023
Study Completion Date
July 14, 2023
Ropivacaïne Hydrochloride by Erector Spinae block
Ropivacaïne Hydrochloride Erector Spinae puncture will be performed with ultrasound guidance. Then 0.50% Ropivacaine hydrochloride will be injected at a dose of 0.6 ml/kg of actual weight, without exceeding 30 ml.
Ropivacaïne Hydrochloride by Paravertebral block
Paravertebral puncture will be performed with ultrasound guidance. Then 0.50% Ropivacaine hydrochloride will be injected at a dose of 0.6 ml/kg of actual weight, without exceeding 30 ml.
Institut Claudius Régaud UICT, Toulouse
Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy
Centre Jean Perrin, Clermont-Ferrand
AP-HP Hôpital Tenon, Paris
Institut Curie, Saint-Cloud
National Cancer Institute, France
OTHER_GOV
Institut Curie
OTHER